All
  • All
  • Insight
  • Research Services
  • Preclinical CRO
  • Animal Resource Bank
CN
中文 English
Aniphe BioLab
Aniphe BioLab
Aniphe BioLab
Aniphe BioLab
Aniphe BioLab

Aniphe BioLab

Aniphe BioLab
Aniphe BioLab
Aniphe BioLab
Aniphe BioLab
Aniphe BioLab

Aniphe BioLab

Aniphe BioLab
Aniphe BioLab
Aniphe BioLab
Aniphe BioLab
Aniphe BioLab

Aniphe BioLab

Technical Services

Disease animal model
Disease animal model

Disease animal model

Accurately recapitulate disease phenotypes, providing a reliable platform for drug efficacy evaluation. We offer customized services for a wide range of disease‑specific animal models, including cerebral ischemia–reperfusion models in rats and mice (MCAO/R), myocardial infarction/myocardial ischemia models (MI), Alzheimer’s disease (AD) models, and more.
Gene Editing and Rapid Propagation
Gene Editing and Rapid Propagation

Gene Editing and Rapid Propagation

The Cre–loxP system can be used to generate knockout mice, enabling tissue-specific genetic modifications. IVF‑ET breeding techniques and customized breeding cycles are short, efficiently accelerating the research process.
Model animal resources
Model animal resources

Model animal resources

Equipped with an SPF‑grade clean animal facility, we offer a variety of strains, including naturally aged mice aged 7–24 months and AD model mice. We provide end‑to‑end services, encompassing breeding, disease modeling and drug administration, genetic identification, and biomarker analysis.
Comprehensive Experimental Services
Comprehensive Experimental Services

Comprehensive Experimental Services

We offer end-to-end services for the development of animal models and the evaluation of drug efficacy and mechanistic studies across oncology, neurological disorders, metabolic diseases, and aging‑related conditions, seamlessly supporting drug‑registration requirements from model generation to data delivery.

Product Center

Old mouse

Available for infants aged 7–18 months, with options for personalized customization and pre‑order. Nationwide door-to-door delivery.

Explore more

Old mouse

AD mouse

Available for infants aged 7–18 months, with options for personalized customization and pre‑order. Nationwide door-to-door delivery.

Explore more

AD mouse

Humanized model

Focusing on the field of laboratory animals and animal experimentation services.

Explore more

Humanized model

Disease model

Accurately recapitulates disease phenotypes, providing a reliable platform for drug efficacy evaluation.

Explore more

Disease model

Tool mouse

Breeding, model establishment and drug administration, genetic identification, and biomarker analysis—all performed in a single step.

Explore more

Tool mouse

About Us

Aniphe BioLab Inc.

Aniphe Biolaboratory Inc.was established in 2018 and is committed to becoming an internationally renowned preclinical pharmacology evaluation company in the new era of biopharmaceutical development. The company has built a comprehensive SPF‑grade laboratory animal center that integrates animal production and experimental services, focusing on laboratory animals and related research support. Its services encompass contract breeding and husbandry, cryopreservation and purification of genetically edited animal models, construction of human disease‑specific animal models, and pharmacological and toxicological testing, covering multiple research areas including oncology, neuroscience, and metabolism. Aniphe BioLab has established a complete R&D, manufacturing, and sales system and management framework, guided by market demand and upholding the principles of pragmatism, truth‑seeking, and mutual benefit. By fostering collaboration among industry, academia, and research institutions, the company drives innovation, serves the life sciences research community and the new‑drug development sector, and contributes to human health and well‑being. 

Explore more

1400 Square meters

Company area

5000 +cage

Number of squirrel cages

10000 +

Service Cases

News and Updates

Frontier Briefing Valuable insights from the article Marketing Campaign
Naming Genetically Engineered Mice (Part II): From Being Understandable to Being Written Correctly

2026-10-29

Naming Genetically Engineered Mice (Part II): From Being Understandable to Being Written Correctly

Learn more

How should a multi-disease composite mouse model be constructed? Let’s take a look at the CKM approach.

2026-10-29

How should a multi-disease composite mouse model be constructed? Let’s take a look at the CKM approach.

Learn more

2026 CKM Guidelines Released: Chronic Diseases Enter the Era of Integrated Cardiorenal-Metabolic Management—It’s Time to Rethink Animal Models

2026-08-12

2026 CKM Guidelines Released: Chronic Diseases Enter the Era of Integrated Cardiorenal-Metabolic Management—It’s Time to Rethink Animal Models

The endocrinology department manages blood glucose, the nephrology department handles proteinuria, the cardiology department oversees blood pressure and atherosclerotic plaques, and the obesity clinic focuses on weight management. Over the past few decades, we have tended to compartmentalize each patient into discrete disease modules, with each specialty addressing only one segment. Yet in reality, disease progression does not conform to departmental boundaries. In this patient, obesity, insulin resistance, hypertension, renal impairment, and cardiovascular risk are, at their core, distinct links in a single pathological cascade—driving one another and amplifying each other.

Learn more

A Guide to Safe Mouse Handling | Manual on Mouse Transport Protocols and Troubleshooting

2026-08-12

A Guide to Safe Mouse Handling | Manual on Mouse Transport Protocols and Troubleshooting

From order placement and inventory preparation to shipment and customer receipt, the transportation of laboratory animals remains a critical aspect of our operations. Unlike ordinary commodities, laboratory animals are subject to a wide range of factors during transit, including distance, weather conditions, temperature, stress, as well as the animals’ age and physiological state.

Learn more

Naming Genetically Engineered Mice (Part II): From Being Understandable to Being Written Correctly

2026-10-29

Naming Genetically Engineered Mice (Part II): From Being Understandable to Being Written Correctly

Learn more

How should a multi-disease composite mouse model be constructed? Let’s take a look at the CKM approach.

2026-10-29

How should a multi-disease composite mouse model be constructed? Let’s take a look at the CKM approach.

Learn more

2026 CKM Guidelines Released: Chronic Diseases Enter the Era of Integrated Cardiorenal-Metabolic Management—It’s Time to Rethink Animal Models

2026-08-12

2026 CKM Guidelines Released: Chronic Diseases Enter the Era of Integrated Cardiorenal-Metabolic Management—It’s Time to Rethink Animal Models

The endocrinology department manages blood glucose, the nephrology department handles proteinuria, the cardiology department oversees blood pressure and atherosclerotic plaques, and the obesity clinic focuses on weight management. Over the past few decades, we have tended to compartmentalize each patient into discrete disease modules, with each specialty addressing only one segment. Yet in reality, disease progression does not conform to departmental boundaries. In this patient, obesity, insulin resistance, hypertension, renal impairment, and cardiovascular risk are, at their core, distinct links in a single pathological cascade—driving one another and amplifying each other.

Learn more

A Guide to Safe Mouse Handling | Manual on Mouse Transport Protocols and Troubleshooting

2026-08-12

A Guide to Safe Mouse Handling | Manual on Mouse Transport Protocols and Troubleshooting

From order placement and inventory preparation to shipment and customer receipt, the transportation of laboratory animals remains a critical aspect of our operations. Unlike ordinary commodities, laboratory animals are subject to a wide range of factors during transit, including distance, weather conditions, temperature, stress, as well as the animals’ age and physiological state.

Learn more

Naming Genetically Engineered Mice (Part II): From Being Understandable to Being Written Correctly

2026-10-29

Naming Genetically Engineered Mice (Part II): From Being Understandable to Being Written Correctly

Learn more

How should a multi-disease composite mouse model be constructed? Let’s take a look at the CKM approach.

2026-10-29

How should a multi-disease composite mouse model be constructed? Let’s take a look at the CKM approach.

Learn more

2026 CKM Guidelines Released: Chronic Diseases Enter the Era of Integrated Cardiorenal-Metabolic Management—It’s Time to Rethink Animal Models

2026-08-12

2026 CKM Guidelines Released: Chronic Diseases Enter the Era of Integrated Cardiorenal-Metabolic Management—It’s Time to Rethink Animal Models

The endocrinology department manages blood glucose, the nephrology department handles proteinuria, the cardiology department oversees blood pressure and atherosclerotic plaques, and the obesity clinic focuses on weight management. Over the past few decades, we have tended to compartmentalize each patient into discrete disease modules, with each specialty addressing only one segment. Yet in reality, disease progression does not conform to departmental boundaries. In this patient, obesity, insulin resistance, hypertension, renal impairment, and cardiovascular risk are, at their core, distinct links in a single pathological cascade—driving one another and amplifying each other.

Learn more

A Guide to Safe Mouse Handling | Manual on Mouse Transport Protocols and Troubleshooting

2026-08-12

A Guide to Safe Mouse Handling | Manual on Mouse Transport Protocols and Troubleshooting

From order placement and inventory preparation to shipment and customer receipt, the transportation of laboratory animals remains a critical aspect of our operations. Unlike ordinary commodities, laboratory animals are subject to a wide range of factors during transit, including distance, weather conditions, temperature, stress, as well as the animals’ age and physiological state.

Learn more

About Us

Partner with us

Why choose Aniphe BioLab?

Compliance Qualification Assurance

The company has earned numerous prestigious honors and certifications, including the “License for the Use of Laboratory Animals,” the “License for the Production of Laboratory Animals,” the “Quality Management System Certification,” as well as designations such as “National High-Tech Enterprise,” “Private Science and Technology Enterprise of Jiangsu Province,” and “National-Level Small and Medium-Sized Science and Technology Enterprise.” These credentials provide robust assurance, solidify the foundation of scientific research, and ensure data compliance suitable for new drug applications.

Mature technology system

A robust platform for model development and breeding, with over 10,000 successful case studies, high model success rates, and strong batch-to-batch consistency. Holder of prestigious honors and certifications, including “Private Science and Technology Enterprise of Jiangsu Province” and “National-Level Technology-Based SME,” we provide rigorous quality assurance to solidify our research foundation. Our data‑compliant solutions are fully eligible for new drug registration submissions.

Efficient delivery capability

5,000+ cage‑space SPF‑grade animal facilities, ample inventory and rapid breeding capabilities ensure on‑demand delivery without delaying your project timeline.

Dedicated service throughout the entire journey

One‑on‑one technical specialist coordination, with end-to-end project management from solution design to data delivery, providing expert technical support and optimization recommendations.

Some partners

Submit